Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for DEE-SWAS
NCT07221968Phase 2Not yet recruiting
- Sponsor
- Hugo W. Moser Research Institute at Kennedy Krieger
- Start
- Jul 2026
- Primary completion
- Jul 2028
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of melatonin in developmental and epileptic encephalopathy with spike wave activation in sleep (DEE-SWAS), sponsored by Hugo W. Moser Research Institute at Kennedy Krieger. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
melatonin
03
Conditions
developmental and epileptic encephalopathy with spike wave activation in sleep (DEE-SWAS)
Beyond the preview
Go deeper on NCT07221968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07221968.